Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 386

1.

Impact of Tumarkin attacks on complaints and work ability in Ménière's disease.

Pyykkö I, Manchaiah V, Zou J, Levo H, Kentala E.

J Vestib Res. 2018 May 22. doi: 10.3233/VES-180634. [Epub ahead of print]

PMID:
29843293
2.

Dizziness in Europe: from licensed fitness to drive to licence without fitness to drive.

Huppert D, Straumann D, Magnusson M, Pyykkö I, Brandt T.

J Neurol. 2018 Mar 13. doi: 10.1007/s00415-018-8806-y. [Epub ahead of print]

PMID:
29536178
3.

Impact of Ménière's Disease on Significant Others' Health and Lives.

Manchaiah V, Pyykkő I, Levo H, Kentala E.

J Am Acad Audiol. 2018 Jan;29(1):63-72. doi: 10.3766/jaaa.16166.

PMID:
29309024
4.

Patient-reported benefits from patient organization magazines and Internet-based peer support in Ménière's disease.

Manchaiah V, Pyykkö I, Zou J, Levo H, Kentala E.

Patient Prefer Adherence. 2017 Oct 26;11:1851-1857. doi: 10.2147/PPA.S142257. eCollection 2017.

5.

Internet-Based Self-Help for Ménière's Disease: Details and Outcome of a Single-Group Open Trial.

Pyykko I, Manchaiah V, Kentala E, Levo H, Juhola M.

Am J Audiol. 2017 Dec 12;26(4):496-506. doi: 10.1044/2017_AJA-16-0068.

PMID:
29049634
6.

Relational quality, illness interference, and partner support in Ménière's disease.

Pyykkö I, Manchaiah V, Zou J, Levo H, Kentala E.

Int J Audiol. 2018 Jan;57(1):69-75. doi: 10.1080/14992027.2017.1367847. Epub 2017 Aug 24.

PMID:
28835146
7.

NANOCI-Nanotechnology Based Cochlear Implant With Gapless Interface to Auditory Neurons.

Senn P, Roccio M, Hahnewald S, Frick C, Kwiatkowska M, Ishikawa M, Bako P, Li H, Edin F, Liu W, Rask-Andersen H, Pyykkö I, Zou J, Mannerström M, Keppner H, Homsy A, Laux E, Llera M, Lellouche JP, Ostrovsky S, Banin E, Gedanken A, Perkas N, Wank U, Wiesmüller KH, Mistrík P, Benav H, Garnham C, Jolly C, Gander F, Ulrich P, Müller M, Löwenheim H.

Otol Neurotol. 2017 Sep;38(8):e224-e231. doi: 10.1097/MAO.0000000000001439. Review.

8.

Internet-based peer support for Ménière's disease: a summary of web-based data collection, impact evaluation, and user evaluation.

Pyykkő I, Manchaiah V, Levo H, Kentala E, Juhola M.

Int J Audiol. 2017 Jul;56(7):453-463. doi: 10.1080/14992027.2017.1282631. Epub 2017 Feb 9.

PMID:
28635496
9.

Biocompatibility of Liposome Nanocarriers in the Rat Inner Ear After Intratympanic Administration.

Zou J, Feng H, Sood R, Kinnunen PKJ, Pyykko I.

Nanoscale Res Lett. 2017 Dec;12(1):372. doi: 10.1186/s11671-017-2142-5. Epub 2017 May 25.

10.

Vestibular syncope: A disorder associated with drop attack in Ménière's disease.

Pyykkö I, Manchaiah V, Zou J, Levo H, Kentala E.

Auris Nasus Larynx. 2018 Apr;45(2):234-241. doi: 10.1016/j.anl.2017.03.023. Epub 2017 May 3.

PMID:
28478076
11.

Do patients with Ménière's disease have attacks of syncope?

Pyykkö I, Manchaiah V, Zou J, Levo H, Kentala E.

J Neurol. 2017 Oct;264(Suppl 1):48-54. doi: 10.1007/s00415-017-8452-9. Epub 2017 Mar 20.

PMID:
28321563
12.

Clinically relevant human temporal bone measurements using novel high-resolution cone-beam CT.

Zou J, Lähelmä J, Arnisalo A, Pyykkö I.

J Otol. 2017 Mar;12(1):9-17. doi: 10.1016/j.joto.2017.01.002. Epub 2017 Jan 19.

13.

Inner ear barriers to nanomedicine-augmented drug delivery and imaging.

Zou J, Pyykkö I, Hyttinen J.

J Otol. 2016 Dec;11(4):165-177. doi: 10.1016/j.joto.2016.11.002. Epub 2016 Nov 25. Review.

14.

The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes.

Mannerström M, Zou J, Toimela T, Pyykkö I, Heinonen T.

Toxicol In Vitro. 2016 Dec;37:113-120. doi: 10.1016/j.tiv.2016.09.012. Epub 2016 Sep 13.

PMID:
27633900
15.

Label-free visualization of cholesteatoma in the mastoid and tympanic membrane using CARS microscopy.

Zou J, Isomäki A, Hirvonen T, Aarnisalo A, Jero J, Pyykkö I.

J Otol. 2016 Sep;11(3):127-133. doi: 10.1016/j.joto.2016.09.001. Epub 2016 Sep 10.

16.

An Overview of Nanoparticle Based Delivery for Treatment of Inner Ear Disorders.

Pyykkö I, Zou J, Schrott-Fischer A, Glueckert R, Kinnunen P.

Methods Mol Biol. 2016;1427:363-415. doi: 10.1007/978-1-4939-3615-1_21. Review.

PMID:
27259938
17.

Multilaboratory evaluation of 15 bioassays for (eco)toxicity screening and hazard ranking of engineered nanomaterials: FP7 project NANOVALID.

Bondarenko OM, Heinlaan M, Sihtmäe M, Ivask A, Kurvet I, Joonas E, Jemec A, Mannerström M, Heinonen T, Rekulapelly R, Singh S, Zou J, Pyykkö I, Drobne D, Kahru A.

Nanotoxicology. 2016 Nov;10(9):1229-42. doi: 10.1080/17435390.2016.1196251. Epub 2016 Jun 28.

18.

Efficient penetration of ceric ammonium nitrate oxidant-stabilized gamma-maghemite nanoparticles through the oval and round windows into the rat inner ear as demonstrated by MRI.

Zou J, Ostrovsky S, Israel LL, Feng H, Kettunen MI, Lellouche JM, Pyykkö I.

J Biomed Mater Res B Appl Biomater. 2017 Oct;105(7):1883-1891. doi: 10.1002/jbm.b.33719. Epub 2016 May 30.

PMID:
27239906
19.

Meniere's disease.

Nakashima T, Pyykkö I, Arroll MA, Casselbrant ML, Foster CA, Manzoor NF, Megerian CA, Naganawa S, Young YH.

Nat Rev Dis Primers. 2016 May 12;2:16028. doi: 10.1038/nrdp.2016.28. Review.

PMID:
27170253
20.

Supplemental Content

Loading ...
Support Center